Asiri Surgical Hospital Income Statement

Financials in millions LKR. Fiscal year is April - March.

Millions LKR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	7,722	7,182	6,620	5,635	5,838
Revenue Growth (YoY)	7.52%	8.49%	17.48%	-3.48%	38.02%
Cost of Revenue	4,374	4,181	3,950	3,405	3,378
Gross Profit	3,348	3,001	2,670	2,229	2,460
Selling, General & Admin	2,117	2,376	2,236	1,274	1,042
Operating Expenses	2,117	2,376	2,236	1,274	1,042
Operating Income	1,231	625.01	433.92	954.96	1,418
Interest Expense	-329.99	-338.39	-615.62	-947.73	-247.04
Interest & Investment Income	-	559.27	767.97	1,218	247.39
Currency Exchange Gain (Loss)	-	3.9	8.22	5.17	-8.01
Other Non Operating Income (Expenses)	718.89	43.4	43.82	30.8	53.34
EBT Excluding Unusual Items	1,620	893.19	638.31	1,261	1,464
Gain (Loss) on Sale of Investments	-	-	-	0.43	7.08
Gain (Loss) on Sale of Assets	-	-0.01	-0.02	-0.44	-0.67
Pretax Income	1,620	893.18	638.29	1,261	1,470
Income Tax Expense	643.29	519.46	515.28	621.37	223.6
Earnings From Continuing Operations	976.47	373.73	123.01	640.03	1,246
Minority Interest in Earnings	-153.58	-108.06	-91.46	-84.91	-61.62
Net Income	822.89	265.67	31.55	555.12	1,185
Net Income to Common	822.89	265.67	31.55	555.12	1,185
Net Income Growth	209.75%	742.03%	-94.32%	-53.14%	44.10%
Shares Outstanding (Basic)	527	528	528	528	528
Shares Outstanding (Diluted)	527	528	528	528	528
Shares Change (YoY)	-0.18%	-	-	-	-
EPS (Basic)	1.56	0.50	0.06	1.05	2.24
EPS (Diluted)	1.56	0.50	0.06	1.05	2.24
EPS Growth	210.31%	742.03%	-94.32%	-53.14%	44.10%
Free Cash Flow	-154.12	-435.07	98.98	248.36	863.27
Free Cash Flow Per Share	-0.29	-0.82	0.19	0.47	1.63
Dividend Per Share	-	0.300	-	-	2.100
Dividend Growth	-	-	-	-	147.06%
Gross Margin	43.36%	41.79%	40.33%	39.56%	42.13%
Operating Margin	15.94%	8.70%	6.55%	16.95%	24.29%
Profit Margin	10.66%	3.70%	0.48%	9.85%	20.29%
Free Cash Flow Margin	-2.00%	-6.06%	1.49%	4.41%	14.79%
EBITDA	1,633	1,015	845.31	1,298	1,736
EBITDA Margin	21.14%	14.13%	12.77%	23.03%	29.74%
D&A For EBITDA	401.76	389.79	411.39	342.75	318.43
EBIT	1,231	625.01	433.92	954.96	1,418
EBIT Margin	15.94%	8.70%	6.55%	16.95%	24.29%
Effective Tax Rate	39.72%	58.16%	80.73%	49.26%	15.21%
Advertising Expenses	-	21.81	26.42	26.35	25.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.